Email Alert | RSS    帮助

中国防痨杂志 ›› 2011, Vol. 33 ›› Issue (10): 637-640.

• 论著 • 上一篇    下一篇

母牛分枝杆菌菌苗预防肺结核的效果与安全性观察

马福宝,许卫国,陈勇,陆敬忠,丁筱竹,王亚龙,范刚   

  1. 南京,江苏省疾病预防控制中心(马福宝、许卫国、陈勇);江苏省宿迁市疾病预防控制中心(陈敬忠);江苏省南京市疾病预防控制中心(丁筱竹);江苏省常州市疾病预防控制中心(王亚龙);江苏省淮安市疾病预防控制中心(范刚)
  • 收稿日期:2010-10-25 出版日期:2011-10-10 发布日期:2012-03-07
  • 通信作者: 马福宝 E-mail:jsmfb@jscdc.cn

Observation of effect and safty on Mycobacterium vaccae for prevention pulmonary tuberculosis

MA Fu-bao,XU Wei-Guo,CHEN yong,LU Jing-zhong,DING Xiao-Zhu,WANG Ya-Long,FAN Gang   

  1. Center for Disease Control and Prevention of Jiangsu Province, Nanjing  210009, China
  • Received:2010-10-25 Online:2011-10-10 Published:2012-03-07
  • Contact: MA Fu-bao E-mail:jsmfb@jscdc.cn

摘要: 目的 观察母牛分枝杆菌菌苗预防肺结核的现场流行病学效果与安全性。方法 采取双盲对照前瞻性研究方法,对当年新入学的小学生、初中生和大学生,根据结核菌素(PPD)皮肤试验结果并以个体为对象数字表法随机分为实验组和对照组,分别接种母牛分枝杆菌菌苗(21 684名)和乙肝疫苗(21 421名),经伦理委员会同意,追踪观察3年2组的肺结核发病率和过敏性疾病的发生率。结果 肺结核的发病率实验组为0.14‰,对照组为0.51‰,差异有统计学意义(χ2=4.671,P=0.031)。过敏性哮喘发生率实验组为0.46‰,对照组为1.31‰,差异有统计学意义(χ2=8.755,P=0.003);过敏性皮肤病发生率实验组为3.04‰,对照组为4.29‰,差异有统计学意义(χ2=4.619,P=0.032)。实验组发热反应发生率为6.69‰(151/21 684),对照组为2.75‰(59/21 421),差异无统计学意义(u=1.71, P>0.05)。结论 母牛分枝杆菌菌苗对预防肺结核、过敏性哮喘和过敏性皮肤病有较好的现场流行病学效果,且母牛分枝杆菌菌苗接种安全性较好。

关键词: 结核, 肺/预防和控制, 母牛分枝杆菌菌苗, 前瞻性研究

Abstract: Objective To observe the epidemiological effect and safety on Mycobacterium vaccae (M. vaccae)for prevention pulmonary tuberculosis. Methods According to the PPD skin test results, double-blind controlled prospective study were conducted in the new students of primary school, middle school and college. All students were randomly divided into experimental group(21 684 cases vaccinated with M. vaccae) and control group(21 421 cases vaccinated with hepatitis B vaccine)。The morbidity of pulmonary tuberculosis and allergic diseases were followed up for 3 years approved by the Ethics Committee of our centre. Results The incidence rate of pulmonary tuberculosis in experimental group and in control group were 0.14‰ and 0.51‰, respectively (χ2=4.671,P=0.031).The incidence rate of allergic asthma in experimental group and in control group were 0.46‰ and 1.31‰, respectively.(χ2=8.755,P=0.003). The incidence rate of allergic skin diseases in experimental group and in control group were 3.04 ‰ and 4.29‰, respectively. (χ2=4.619,P=0.032). All differences above were significant statistically. However, the incidence of fever were not significant statistically (u=1.71,P<0.05) in experimental group with 6.69‰ (151/21684) and in control group with 2.75‰ (59/21 421). Conclusion M. vaccae has good epidemiological effect on the prevention of pulmonary tuberculosis, allergic asthma and allergic skin diseases M. vaccae is also safe for injection.

Key words: Tuberculosis, pulmonary/prevention and control, Mycobacterium vaccae vaccine, prospective study